Genetically engineered T cells for the treatment of cancer

@inproceedings{Essand2013GeneticallyET,
  title={Genetically engineered T cells for the treatment of cancer},
  author={Magnus Essand and Angelica Loskog},
  booktitle={Journal of internal medicine},
  year={2013}
}
T-cell immunotherapy is a promising approach to treat disseminated cancer. However, it has been limited by the ability to isolate and expand T cells restricted to tumour-associated antigens. Using ex vivo gene transfer, T cells from patients can be genetically engineered to express a novel T cell receptor or chimeric antigen receptor to specifically recognize a tumour-associated antigen and thereby selectively kill tumour cells. Indeed, genetically engineered T cells have recently been… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 5 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 13 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 119 references

Similar Papers

Loading similar papers…